Institut BergoniéBordeaux, Aquitaine, France
Disclosure information not submitted.
Paper 24 - MILADEMETAN VS. TRABECTEDIN IN PATIENTS WITH DEDIFFERENTIATED LIPOSARCOMA: RESULTS FROM THE PHASE 3 MANTRA STUDY
Thursday, November 2, 20234:00 PM – 5:30 PM
Paper 73 - PRE-CLINICAL ACTIVITY OF ADCT-601, AN ANTIBODY-DRUG CONJUGATE TARGETING AXL IN SOFT-TISSUE SARCOMA
Saturday, November 4, 202311:30 AM – 1:00 PM